- 2 days & nights inpatient stay
- 7 quick follow-up appointments
Participants in this research are paid up to $1,500 for their time and this clinical trial has been approved by an independent ethics committee.
About the study
Breast cancer is the most common form of cancer diagnosed in women. It is estimated that in 2018 approximately 49 Australian women are diagnosed with breast cancer every day.
We are looking for healthy male participants for this study.
Participants will be given an FDA approved dose of the drug. At this stage of testing we are not looking at whether it will have any therapeutic value, instead we are looking at how a healthy body metabolises the drug and will then use the data acquired for further stages of testing. As a participant you will be randomized to receive either NeuCeptin, Herceptin-EU or Herceptin-US as a single dose.
How do I find out more?
If you are interested in participating or would like more information, please register below.
If you have already registered with us but would like more information regarding this study, please call 1800 243 733 or email firstname.lastname@example.org and quote “Gentleman’s Study”.